MERRIMACK PHARMACEUTICALS INC Annual Earnings Per Share, Basic in USD/shares from 2021 to 2023

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Merrimack Pharmaceuticals Inc quarterly/annual Earnings Per Share, Basic history and growth rate from 2021 to 2023.
  • Merrimack Pharmaceuticals Inc Earnings Per Share, Basic for the quarter ending March 31, 2024 was 13.9 USD/shares.
  • Merrimack Pharmaceuticals Inc Earnings Per Share, Basic for the twelve months ending March 31, 2024 was 13.9 USD/shares.
  • Merrimack Pharmaceuticals Inc annual Earnings Per Share, Basic for 2023 was -0.08 USD/shares, a 27.3% increase from 2022.
  • Merrimack Pharmaceuticals Inc annual Earnings Per Share, Basic for 2022 was -0.11 USD/shares, a 38.9% increase from 2021.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $0 +$0.03 +27.3% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-07
2022 $0 +$0.07 +38.9% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-07
2021 $0 Jan 1, 2021 Dec 31, 2021 10-K 2023-03-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.